Axitinib-Induced Hypothyroidism as a Predictor of Long-Term Survival in Patients with Metastatic Renal Cell Carcinoma
Conclusion: Our findings indicate that hypothyroidism may be a predictive marker of therapeutic effect of axitinib against mRCC.Urol Int
Source: Urologia Internationalis - Category: Urology & Nephrology Source Type: research
More News: Cancer & Oncology | Carcinoma | Hormones | Hypertension | Hypothyroidism | Japan Health | Kidney Cancer | Levothyroxine | Renal Cell Carcinoma | Study | Synthroid | Thyroid | Thyroid Cancer | Urology & Nephrology | Women